Gentofte, Denmark

Peter Nordkild

This inventor holds 3 USPTO granted patents and 4 published patent applications and 5 EPO patents. Top assignees: Novozymes A/s, Arts Biologics A/s. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Nordkild. Retrieved from https://idiyas.com/inventor/peter-nordkild

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Peter Nordkild - Innovative Danish Inventor

Introduction: Peter Nordkild is a renowned inventor hailing from Gentofte, Denmark, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Peter Nordkild holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Peter Nordkild has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Peter Nordkild has collaborated with top companies, innovative startups, and talented individuals to bring his inventions to life, fostering a culture of creativity and innovation.

Conclusion: Peter Nordkild's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the landscape of technology for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…